Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline for the Treatment of DSM 5 Cannabis Use Disorder in Adults

NCT03980561 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT03980561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03980561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline for the Treatment of DSM 5 Cannabis Use Disorder in Adults
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2020
Completion date
December 1, 2023
Enrollment
174 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder